Divya Sharma | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Dr. Divya Sharma | Signal Transduction Mechanisms | Best Researcher Award

Amity University, Punjab | India

Dr. Divya Sharma is an accomplished researcher and academic in Computer Science and Engineering, specializing in information security, cyber vulnerabilities, and electronic medical image protection. She completed her B.Tech. in CSE from Shaheed Udham Singh College of Engineering & Technology, Mohali, followed by an M.Tech. in CSE from Rayat & Bahra Institute of Engineering & Biotechnology, Kharar, and earned her Ph.D. from Chitkara University in 2025 with a CGPA of 9.15. Over her career, she has contributed significantly to the field of cybersecurity, publishing research on electronic medical image security and hybrid edge-based steganography with three-layered cryptography, presented at conferences including ICOECA-2024, CUDC-2023, and ADSSS-2023. She has actively engaged in faculty development, attending programs on cyber vulnerabilities, emerging engineering trends, and ICT-based classroom communication. Currently, she serves as an Assistant Professor in the Department of Information Technology at Panjab University SSG Regional Center, Hoshiarpur. Dr. Sharma’s work has been recognized for its impact, with multiple papers cited in peer-reviewed venues, reflecting her growing scholarly influence. She has also participated in numerous short-term courses and industry training programs, enhancing her expertise in relational databases, VB.NET, and applied data science, contributing to both teaching excellence and research innovation.

Profiles: Google Scholar | Orcid

Featured Publications:

Sharma, D. (2024, April 18–19). Electronic medical images security and privacy techniques. In 4th International Conference on Expert Clouds and Applications (ICOECA-2024), RV College of Engineering, Bengaluru, India.

Sharma, D. (2024). Hybrid security of EMI using edge-based steganography and three-layered cryptography. In Applied Data Science and Smart Systems (pp. 278–290). CRC Press.

Sharma, D., & Prabha, C. (2023, May 5–6). Security and privacy aspects of electronic health records: A review. In 2023 International Conference on Advancement in Computation & Computer Technologies (ICACCT). IEEE.

Sharma, D., & Kawatra, R. (2022, July 29–30). Security techniques implementation on big data using steganography and cryptography. In ICT Analysis and Applications (pp. 279–302). Springer Nature Singapore.

Sharma, D. (2015, Sept 4–5). Implementing chi-square method and even mirroring for cryptography of speech signal using MATLAB. In 1st International Conference on Next Generation Computing Technologies (NGCT-2015) (pp. 394–397). IEEE.

Sharma, D. (2015, Dec 21–22). Steganography of speech signal into an image. In 2nd International Conference on Recent Advances in Engineering and Computational Sciences (RAECS-2015) (pp. 1–4). IEEE.

Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Published on by Cell Biologist

Dr. Kai Zhao | Signal Transduction Mechanisms | Cell Biology Research Award

Dr. Kai Zhao | shandong first medical university | China

Kai Zhao is a dedicated biomedical scientist specializing in cell biology and translational medical research. Affiliated with the Central Hospital and Shandong First Medical University, Kai has focused on molecular mechanisms underlying diseases such as osteosarcoma and neurodegeneration. Their expertise includes mitophagy regulation, exosomal gene biomarkers, and multi-omics analyses, aiming to discover novel therapeutic targets. Kai has contributed significantly to understanding how cellular degradation pathways influence disease progression, with published work in prominent journals. They hold key roles in both clinical and research settings, bridging basic science and patient care. Their collaborative work and innovative approach have garnered attention in the biomedical community, underscoring their role as a rising leader in cell biology research.

Publication Profile: 

Orcid

Education:

Kai Zhao completed their foundational studies in medicine at a prestigious medical university in China, followed by advanced graduate training focusing on cellular and molecular biology. Their education provided a strong grounding in clinical medicine combined with rigorous laboratory research skills. They further specialized through postgraduate work that integrated molecular biology techniques and omics technologies, developing expertise in the mechanisms of disease at a cellular level. This multidisciplinary education enabled Kai to pursue research at the interface of clinical practice and experimental biology. They have also completed specialized training in bone biomechanics and metabolism, as well as spinal surgery, enhancing their ability to conduct translational research. Continuous professional development through workshops, conferences, and collaborative projects complements their formal education, keeping them updated on cutting-edge scientific advances.

Experience:

Kai Zhao has extensive experience working at the Central Hospital Affiliated with Shandong First Medical University, where they contribute both clinically and in research. Their experience includes investigating molecular pathways in osteosarcoma and neurodegenerative models using cell lines such as SH-SY5Y. Kai has led projects applying multi-omics data to identify exosomal gene biomarkers and therapeutic targets like mifepristone. Their role in the Spinal Surgery Department and Bone Biomechanics Laboratory has provided hands-on clinical insight, informing their research on bone and spinal disorders. Kai collaborates with multidisciplinary teams, combining clinical knowledge with molecular techniques. Their publication record reflects proficiency in advanced methodologies such as mitophagy analysis, molecular degradation pathways, and biomarker discovery. Kai also mentors junior researchers and participates in academic dissemination through publications and conferences, demonstrating leadership and a commitment to advancing cell biology research.

Research Focus:

Kai Zhao’s research centers on the molecular and cellular mechanisms driving disease, with an emphasis on mitophagy, exosomal biomarkers, and multi-omics analyses. They investigate how cellular quality control systems, such as the PINK1-mediated mitophagy pathway, contribute to neurodegenerative diseases and cancer progression, specifically osteosarcoma. By combining genomic, proteomic, and transcriptomic data, Kai aims to identify novel gene biomarkers within exosomes that can serve as diagnostic or therapeutic targets. One highlighted therapeutic candidate from their work is mifepristone, revealed through integrative multi-omics to be effective against osteosarcoma. Their research integrates cellular biology with clinical insights, particularly in bone metabolism and spinal diseases, aiming for translational impact. Overall, Kai’s focus is on uncovering how disruptions in cellular degradation and intercellular communication contribute to disease, leveraging multi-disciplinary approaches to develop targeted therapies.

Publication Top Notes:

    • Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi‐Omics Analysis

    • IRGM promotes the PINK1-mediated mitophagy through the degradation of Mitofilin in SH-SY5Y cells

Conclusion:

Kai Zhao is a promising and capable researcher whose work directly contributes to cutting-edge cell biology, particularly in disease mechanisms. Their multi-omics and cellular degradation studies mark them as an excellent candidate for the Cell Biology Research Award.

Yanhua Liang | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yanhua Liang | Signal Transduction Mechanisms | Best Researcher Award

Prof. Yanhua Liang, Shenzhen Hospital of Southern Medical University, China

Dr. Yan-Hua Liang,  is a distinguished dermatologist, academic, and researcher. He serves as Chairman and Chief Physician in the Department of Dermatology at Shenzhen Hospital, Southern Medical University. With over two decades of clinical and research experience, he is widely recognized for his contributions to dermatological science and translational medicine. Dr. Liang holds dual PhDs and has trained internationally, including a postdoctoral fellowship at The Jackson Laboratory in the U.S. His commitment to advancing psoriasis therapy, dermatological immunology, and healthcare system improvements is evident in his prolific publication record and mentorship roles. He actively collaborates with global experts and consistently publishes in high-impact journals. Through a career grounded in clinical excellence and research innovation, Dr. Liang continues to shape the field of dermatology in China and beyond.\

Publication Profile: 

Scopus

Strengths for the Award

  1. Proven Academic Excellence

    • Holds M.D., dual Ph.D.s, and completed a prestigious postdoctoral fellowship at The Jackson Laboratory, USA — reflecting strong scientific and international credentials.

  2. Clinical Leadership & Longstanding Experience

    • Over 20 years in dermatology, currently serving as Chairman and Chief Physician at a major university-affiliated hospital.

  3. Research Output & Innovation

    • 10+ high-quality peer-reviewed publications (2023–2025) in leading journals like Scientific Reports, Drug Safety, Frontiers in Medicine, and Dermatology.

    • Focus on real-world studies, biologic therapies, psoriasis, autoimmune skin diseases, and translational dermatology — addressing clinically relevant problems.

  4. Mentorship and Academic Contributions

    • Active Ph.D. supervisor, guiding the next generation of dermatological researchers.

    • Collaborates with both domestic and international institutions, boosting China’s contribution to global dermatology research.

  5. Multidisciplinary Impact & Public Health Relevance

    • Involved in infectious disease preparedness (Monkeypox) and healthcare system education for medical professionals.

Areas for Improvement

  1. International Visibility & Awards

    • While the academic record is strong, international keynote roles, global society leadership, or major global awards are not yet highlighted. These would further elevate his candidacy.

  2. Broader Interdisciplinary Integration

    • Could explore collaborative work in AI-driven dermatology, digital diagnostics, or bioinformatics, which are emerging fields in skin science.

Education (150 words)

Dr. Liang’s academic journey reflects a steadfast pursuit of medical excellence. He earned his Bachelor of Medicine from Gannan Medical University (1996–2001), followed by a Master of Science and Ph.D. in Dermatology from Anhui Medical University (2001–2007). To further enrich his scientific acumen, he completed a Postdoctoral Fellowship at The Jackson Laboratory, USA (2007–2010), a premier institution for biomedical research. His education combines strong clinical training with rigorous research methodology, particularly in genetics and dermatological sciences. Dr. Liang’s dual PhDs signify his interdisciplinary focus and commitment to integrating basic science into clinical innovation. His international training has enabled him to bridge Eastern and Western medical practices and adopt a global perspective in addressing skin diseases. With a strong foundation in immunodermatology, translational medicine, and evidence-based treatments, Dr. Liang’s academic background is a cornerstone of his success as a clinician-scientist and mentor.

Experience (150 words)

Dr. Yan-Hua Liang has over 20 years of experience in clinical dermatology and academic leadership. He currently holds the title of Chairman and Professor at the Department of Dermatology, Shenzhen Hospital, Southern Medical University (since 2016). Prior to this, he was a Professor at Nanfang Hospital, also part of Southern Medical University (2012–2015). His clinical expertise spans psoriasis, atopic dermatitis, and autoimmune skin diseases, with a focus on biologic therapies and translational dermatology. He has treated thousands of patients and led major clinical trials in China. As a Ph.D. supervisor, Dr. Liang has mentored numerous postgraduate students and emerging researchers. His leadership has helped modernize dermatological practices, elevate research standards, and foster international collaborations. Recognized for his medical innovations and deep patient care, Dr. Liang stands out as a thought leader in dermatology in the Greater Bay Area and nationally.

Research Focus (150 words)

Dr. Liang’s primary research interests lie in psoriasis treatment, immunodermatology, and translational skin research. He is a pioneer in real-world data analysis of biologic therapies for psoriasis, as demonstrated in several of his prospective, multicenter studies. His focus also includes the gut-skin axis, autoimmune dermatoses, and health policy studies aimed at improving access to dermatological care. In recent years, he has expanded his work into emerging infectious diseases like monkeypox, integrating public health into clinical dermatology. His work is often collaborative, involving multi-disciplinary teams and cross-border research. Dr. Liang is especially committed to improving healthcare delivery systems in dermatology, with a unique emphasis on evidence-based treatment, quality of life metrics, and healthcare worker training. His future focus aims to further explore microbiome-immune interactions in skin disease and introduce AI-driven diagnostic support systems. His research portfolio aligns with global dermatological priorities, positioning him as a leader in innovation and care.

Publications – One-line Format with Emojis

  1.  Cutaneous and systemic improvements in psoriasis after biologics in real-world study – Scientific Reports, 2025

  2.  Gut microbiota and psoriasis: A systematic review – Eur J Pharmacol, 2025

  3.  Hereditary Angioedema in China: Awareness and Advocacy from Greater Bay to Global – Clin Exp Allergy, 2025

  4.  Healthcare workers’ monkeypox knowledge and confidence survey – World J Clin Cases, 2025

  5.  Reducing recurrence of Condyloma Acuminatum via lesional auto-transplantation – J Cosmetics, Dermatol Sci Appl, 2024

  6.  Atopic Dermatitis: From Bench to Bedside – Front Med, 2024

  7.  Ixekizumab safety in Chinese plaque psoriasis patients – 12-week observational study – Drug Saf, 2024

  8. Effectiveness of Ixekizumab in special area involvement psoriasis patients – Dermatol Ther (Heidelb), 2024

  9. Quality of life and predictors of complete skin clearance in psoriasis – Dermatology, 2023

  10. Ixekizumab safety and efficacy in Chinese psoriasis patients – Prospective real-world study – Adv Ther, 2023

Conclusion

Dr. Yan-Hua Liang is a highly accomplished clinician-scientist whose integrated focus on clinical excellence, academic mentorship, and research productivity positions him as a leading candidate for the Best Researcher Award. His commitment to real-world research, particularly in psoriasis and biologic therapy, is both impactful and timely.

Given his sustained contributions, ongoing innovative work, and national academic leadership, Dr. Liang exemplifies the qualities of a modern, translational researcher who is significantly advancing dermatology in China and beyond.

Ning Xu | Signal Transduction Mechanisms | Best Research Article Award

Published on by Cell Biologist

Dr. Ning Xu | Signal Transduction Mechanisms | Best Research Article Award

Dr. Ning Xu , China Agricultural University , China

Ning Xu is an accomplished scientist specializing in plant immunity and plant-pathogen interactions. Currently, he serves as an Associate Professor at the College of Plant Protection, China Agricultural University. With a strong academic background and a wealth of research experience, he has significantly contributed to understanding plant defense mechanisms, particularly in relation to bacterial and fungal pathogens. His work, published in top-tier journals, explores how plants perceive and respond to pathogens at the molecular level, with a focus on lectin receptor-like kinases, autophagy, and signaling pathways in plant immunity. His research is pivotal in enhancing crop protection strategies, particularly in rice and other key crops.

Publication Profile: 

Orcid

Strengths for the Award:

Dr. Ning Xu’s research portfolio demonstrates significant contributions to plant immunity and pathogen interactions, showcasing both depth and innovation. His publications address critical aspects of plant-pathogen interactions and the molecular mechanisms that govern plant immune responses. For example, his recent work on the role of lectin receptor-like kinases (LRKs) in plant immunity and his exploration of plant autophagy and protein signaling pathways are highly impactful. The non-invasive Raman spectroscopy method for detecting bacterial leaf blight and streak is a standout, as it offers practical, cutting-edge solutions for real-time monitoring of plant diseases. Dr. Xu’s consistent publication in high-impact journals and his cross-disciplinary research further highlight his ability to contribute to agricultural and environmental advancements.

Areas for Improvement:

While Dr. Xu’s research is impressive in its scope and application, it could benefit from increased collaborative studies across diverse agricultural systems and crop species. Future work that expands into more field-based studies would provide valuable insights into how laboratory-based findings translate to real-world agricultural scenarios. Furthermore, continued exploration of plant-microbe interactions with other crop diseases outside rice, including leguminous plants, could broaden the impact of his work.

Education:

Ning Xu pursued a Bachelor’s degree in Biotechnology at Qingdao University (2002-2006). He then completed a Ph.D. in Genetics at the Institute of Microbiology, Chinese Academy of Sciences (2006-2012), where he focused on molecular genetics and plant immunity. During his Ph.D. studies, he developed a strong foundation in understanding complex plant-pathogen interactions, which set the stage for his future research career. His education has been complemented by his extensive professional experience, allowing him to bridge theoretical knowledge with practical, cutting-edge research in plant protection.

Experience:

Dr. Ning Xu began his professional journey as an Assistant Researcher at the Institute of Microbiology, Chinese Academy of Sciences (2012-2020), where he honed his skills in molecular genetics and plant pathology. He was promoted to Associate Researcher from 2020 to 2021, where he continued to expand his research on plant immune responses and bacterial pathogens. In 2021, he transitioned to his current role as Associate Professor at the College of Plant Protection, China Agricultural University. His career has been marked by a commitment to advancing plant defense research, with a focus on improving agricultural practices and crop resilience against diseases.

Research Focus:

Ning Xu’s research primarily focuses on plant immunity, particularly how plants detect and respond to pathogens. His work delves into the molecular mechanisms underlying plant immune responses, such as the role of lectin receptor-like kinases in pathogen recognition, autophagy in plant defense, and how bacterial effectors manipulate plant signaling pathways. Xu also investigates non-invasive techniques for disease detection, such as Raman spectroscopy, to improve early diagnosis and intervention. His contributions to understanding the interplay between plants and pathogens aim to improve crop protection strategies and enhance agricultural productivity, particularly in the face of rising global food security challenges.

Publications Top Notes:

  1. Single-cell and spatial transcriptomics reveals a stereoscopic response of rice leaf cells to Magnaporthe oryzae infection 🌾🔬

  2. Noninvasive Raman Spectroscopy for the Detection of Rice Bacterial Leaf Blight and Bacterial Leaf Streak 🌾🔍

  3. Coronatine orchestrates ABI1-mediated stomatal opening to facilitate bacterial pathogen infection through importin β protein SAD2 🌱💧

  4. The cocoon into a butterfly: why the HVA22 family proteins turned out to be the reticulophagy receptors in plants? 🐛🦋

  5. Ligand recognition and signal transduction by lectin receptor-like kinases in plant immunity 🌿🔑

  6. The Pseudomonas syringae effector AvrPtoB targets abscisic acid signaling pathway to promote its virulence in Arabidopsis 🌾🦠

  7. Bacterial effector targeting of a plant iron sensor facilitates iron acquisition and pathogen colonization 🍂🦠

  8. A plant lectin receptor-like kinase phosphorylates the bacterial effector AvrPtoB to dampen its virulence in Arabidopsis 🌱⚡

  9. A Lectin Receptor-Like Kinase Mediates Pattern-Triggered Salicylic Acid Signaling 🌿🔬

  10. The bacterial effector AvrB-induced RIN4 hyperphosphorylation is mediated by receptor-like cytoplasmic kinase complex in Arabidopsis 🌿💡

  11. Identification and Characterization of Small RNAs in the Hyperthermophilic Archaeon Sulfolobus solfataricus 🔬🧬

Conclusion:

Dr. Ning Xu is undoubtedly a leading figure in the field of plant immunology. His innovative research on molecular mechanisms in plant defense, especially in the context of bacterial and fungal diseases, positions him as an ideal candidate for the Best Research Article Award. His research not only pushes the boundaries of basic science but also offers practical applications that could benefit global agriculture by improving disease detection, prevention, and crop resilience.

 

 

 

Liquan Huang | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Liquan Huang | Signal Transduction Mechanisms | Best Researcher Award

Prof. Dr. Liquan Huang , Zhejiang University – Zijingang Campus , China

Liquan Huang is a distinguished molecular biologist specializing in taste transduction and chemosensory research. He completed his Ph.D. in Molecular Biology from Yale University in 1996 under Dr. Michael Lerner and pursued postdoctoral training at Mount Sinai School of Medicine, New York University. With extensive experience in molecular physiology, Dr. Huang has made significant contributions to sensory perception and signaling pathways. Currently, he serves at Zhejiang University, China, where he leads groundbreaking research on G-protein signaling and taste receptor mechanisms. His work has been widely published in top-tier journals, influencing the fields of neuroscience and molecular biology. Dr. Huang has mentored several postdoctoral researchers and contributed to organizing international scientific conferences. His research on sensory transduction has broad applications, including food sciences and human health. His dedication to advancing scientific knowledge makes him a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Research Contributions – Dr. Liquan Huang has an impressive publication record in high-impact journals such as Nature Neuroscience, Journal of Neuroscience, eLife, and PLoS Genetics. His work spans molecular biology, neurophysiology, taste receptor studies, and virology, showing a broad impact in multiple scientific disciplines.

  2. Significant Scientific Impact – His research on taste receptors, G-protein signaling, and environmental viromes has contributed significantly to the understanding of molecular signaling pathways, sensory biology, and viral ecology. His discoveries, such as the pseudogenization of sweet receptors in cats and the role of Gγ13 in inflammation resolution, have broad implications.

  3. Funding and Recognitions – Dr. Huang has received multiple fellowships and research grants, including the Morley R. Kare Fellowship and Small Research Grant Program Award, demonstrating sustained recognition and funding for his work.

  4. Mentorship and Training – Having trained multiple postdoctoral fellows and graduate students, he has contributed to the scientific community by fostering new talent in molecular biology and neuroscience.

  5. International Collaborations and Professional Affiliations – As a member of esteemed organizations like the New York Academy of Sciences, Association for Chemoreception Sciences, and Society for Neuroscience, and as an organizer of major scientific meetings, he has actively contributed to the global research community.

  6. Recent Cutting-Edge Research – His recent work on environmental viromes, the evolution of human pathogenic RNA viruses, and G-protein-mediated inflammation resolution shows his ability to evolve with emerging research trends.

Areas for Improvement:

  1. Diversity of Funding Sources – While Dr. Huang has received multiple research grants, expanding his funding from diverse international sources and large-scale collaborative grants could further support high-impact research.

  2. Broader Public Engagement – Increased engagement in public science communication, industry collaborations, and policy-making could enhance his influence beyond academia.

  3. Interdisciplinary Expansion – While his research is already multidisciplinary, extending collaborations into areas such as AI-driven bioinformatics, synthetic biology, or applied therapeutics could amplify the translational impact of his work.

Education:

Dr. Liquan Huang has a strong academic background in biology and molecular sciences. He obtained his Ph.D. in Molecular Biology from Yale University in 1996, where he was mentored by Dr. Michael Lerner. Prior to this, he earned an M.Ph. in Biology from Yale University in 1993. His foundational training in cell biology and anatomy began at New York Medical College in 1991. These rigorous academic pursuits equipped him with expertise in molecular and cellular mechanisms, particularly in sensory and chemosensory research. His education laid the groundwork for his later advancements in taste receptor studies and G-protein signaling pathways. His tenure at these prestigious institutions provided him with a strong theoretical and experimental foundation, allowing him to excel in interdisciplinary research. His academic excellence was further recognized through fellowships at Yale University and New York Medical College, highlighting his commitment to scientific innovation.

Experience:

Dr. Liquan Huang has an extensive research and academic career spanning over three decades. He began his career as an Assistant Researcher at the Institute of Genetics, Academia Sinica, China (1987–1990). Following his doctoral studies, he pursued postdoctoral research at Mount Sinai School of Medicine, New York University (1996–2000) under Dr. Robert F. Margolskee. He later became an Instructor in the Department of Physiology and Biophysics at Mount Sinai School of Medicine (2000–2002). Currently, he is a researcher and faculty member at Zhejiang University, leading studies in molecular physiology and taste transduction. Dr. Huang has also trained multiple postdoctoral fellows and collaborated on high-impact research. His expertise in sensory biology has led to numerous publications and organizing roles in international conferences. His contributions to neuroscience, molecular biology, and sensory perception establish him as a leading figure in the field.

Awards and Honors:

🏅 Morley R. Kare Fellowship (2004–2006) – Recognized for excellence in chemosensory research.
🎖 Small Research Grant Program Award (R03 DC05154) (2002–2005) – Supported research on molecular taste mechanisms.
🏆 Individual National Research Service Award (F32DC00310) (1998–2000) – Awarded for outstanding postdoctoral research contributions.
🥇 Institutional National Research Service Award (T32DA07135) (1997–1998) – Recognized for research excellence in molecular biology.
🎓 Yale University Fellowship (1991–1996) – Prestigious scholarship for Ph.D. studies in Molecular Biology.
🎖 New York Medical College Fellowship (1991) – Awarded for academic excellence in cell biology training.

Research Focus:

🔬 Taste Transduction & Chemosensory Signaling – Investigating molecular mechanisms of taste receptor activation.
🧬 G-Protein Signaling Pathways – Studying Gγ13 subunit’s role in sensory processing and inflammation resolution.
🦠 Virology & Environmental Microbiology – Exploring deep-sea RNA viromes and their evolutionary significance.
🩺 Biomedical Applications – Examining taste receptor implications in human health and disease.
🍽 Food Science & Peptidomics – Identifying bioactive peptides with taste-modulating properties.

Publications Top Notes📚:

1️⃣ Gγ13 colocalizes with gustducin in taste receptor cells – Nature Neuroscience 🧠
2️⃣ Tas1r3 encodes a new taste receptor – Nature Genetics 🧬
3️⃣ Transient receptor potential channel in taste receptor cells – Nature Neuroscience ⚡
4️⃣ G protein subunit G13 in retinal ON bipolar cells – Journal of Comparative Neurology 👁
5️⃣ Polymorphisms in Tas1r3 gene affect saccharin preference – Journal of Neuroscience 🧪
6️⃣ Cats’ indifference toward sugar due to receptor pseudogenization – PLoS Genetics 🐱
7️⃣ Voltage-gated chloride channel in taste bud cells – Journal of Biological Chemistry 🌊
8️⃣ Human taste: peripheral anatomy & transduction – Advances in Otorhinolaryngology 👅
9️⃣ Interferon pathways activated in taste bud cells – Journal of Neuroscience 🦠
🔟 Bitter peptides activate human bitter receptors – Biochemical and Biophysical Research Communications 🍵

Conclusion:

Dr. Liquan Huang’s extensive contributions to molecular biology, neuroscience, and virology, combined with his mentorship, international collaborations, and leadership in scientific meetings, make him a strong candidate for the Best Researcher Award. While there is always room for growth in funding diversification and interdisciplinary expansion, his body of work demonstrates excellence and innovation in his field.

Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Dr. Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Ranran Li , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , China

Dr. Ranran Li is an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine in Shanghai, China. She earned her Ph.D. from the University Medical Center of Groningen, Netherlands, in 2015, before returning to Shanghai to focus on critical care medicine. Her research centers on sepsis-associated endothelial dysfunction and its underlying molecular mechanisms. Over the years, Dr. Li’s work has provided valuable insights into the role of metabolic disorders and post-translational modifications in regulating endothelial inflammation and coagulation during sepsis. She has published extensively in reputable journals and holds several patents. Her recent findings suggest potential therapeutic targets for the treatment of sepsis and related complications, including endothelial dysfunction and organ injury.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Ranran Li is a distinguished researcher with notable expertise in the mechanisms of sepsis-associated endothelial dysfunction. Her work in identifying the role of metabolic disorders and post-translational modifications in sepsis has been pivotal in advancing the understanding of vascular inflammation and coagulation during critical illness. Her research has led to several high-impact publications and patents, showcasing her contributions to the field. Furthermore, Dr. Li’s interdisciplinary approach, combining metabolic biology, cell signaling, and translational medicine, has provided valuable therapeutic targets for the treatment of sepsis and endothelial dysfunction. Her collaborations with international experts enhance her work’s impact and broaden the scope of her research.

Areas for Improvements:

While Dr. Li’s research has been extensive and groundbreaking, future improvements could include increased collaborations with industry partners to accelerate the translation of her findings into clinical therapies. Expanding her professional network through international collaborations in other areas of critical care medicine could also provide new perspectives and avenues for innovation. Additionally, engaging in larger-scale clinical studies might help further validate her findings in human models.

Education

Dr. Ranran Li obtained her Ph.D. in Medical Sciences from the University Medical Center of Groningen, Netherlands, from 2011 to 2015. During her doctoral studies, she focused on the molecular mechanisms of sepsis and its impact on vascular endothelial dysfunction. Her Ph.D. research laid the foundation for her ongoing investigations into the pathophysiology of sepsis and endothelial injury. Following her Ph.D., she joined Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, in 2016 as an associate researcher in the Department of Critical Care Medicine. Here, Dr. Li furthered her research into sepsis, vascular inflammation, and metabolic disorders. She has developed an expertise in endothelial dysfunction and coagulation, specifically in the context of sepsis-induced organ injuries. Dr. Li’s comprehensive academic training, both in Europe and China, has significantly contributed to her innovative research work and international collaborations.

Experience:

Dr. Ranran Li has been serving as an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, since 2016. Prior to this, she earned her Ph.D. from the University Medical Center of Groningen in the Netherlands, where she focused on sepsis and endothelial dysfunction. In her current position, Dr. Li has worked extensively on understanding the mechanisms underlying sepsis-associated endothelial dysfunction, with a particular focus on metabolic disorders and post-translational modifications. Her work has provided critical insights into the role of fatty acid metabolism, insulin resistance, and histone modifications in regulating endothelial inflammation and coagulation activation in sepsis. Dr. Li’s research has led to multiple publications in high-impact journals and the filing of patents for innovative therapeutic approaches. She collaborates with leading researchers in the Netherlands and has contributed significantly to the understanding of vascular injury and its therapeutic targets in sepsis.

Research Focus:

Dr. Ranran Li’s research focuses on the molecular mechanisms of sepsis-associated endothelial dysfunction, with a particular emphasis on metabolic disorders and post-translational modifications. She has been exploring how fatty acid metabolism, glucose-lipid metabolism, and protein acetylation influence endothelial cells during sepsis, leading to organ injury. Her research has highlighted the role of metabolic shifts, including the activation of pathways like AMPK/PKA, in endothelial inflammation and coagulation activation. Dr. Li has also studied the role of histone modifications, including lactylation, in promoting endothelial ferroptosis and dysfunction during sepsis-induced lung injury. She has been pioneering the exploration of metabolic signaling pathways and their potential as therapeutic targets for managing sepsis-related endothelial damage. Her work aims to identify novel strategies to prevent or mitigate vascular injury in septic patients. Dr. Li’s findings have led to both patents and high-impact publications in critical care and translational medicine.

Publications Top Notes:

  1. Shiyuan He et al., Fatty acid synthesis promotes mtDNA release via ETS1-mediated oligomerization of VDAC1 facilitating endothelial dysfunction in sepsis-induced lung injury 🧬🫁 Cell Death and Differentiation, 2025
  2. Ranran Li et al., ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury 💉🧪 Cell Death and Disease, 2023
  3. Jie Liu et al., Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery 🧬💉 Nano Today, 2025
  4. Fangchen Gong et al., H3K14la drives endothelial dysfunction in sepsis-induced ARDS by promoting SLC40A1/transferrin-mediated ferroptosis 🧬🔥 MedComm, 2025
  5. Jiayin Cui et al., Herbal-based Xuebijing injection ameliorated vascular endothelial dysfunction via inhibiting ACLY/MYB/RIG-I axis in sepsis-associated lung injury 🌱💊 Phytomedicine, 2025
  6. Shasha Lu et al., GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage 💨🧪 Respiratory Research, 2024
  7. Rui Tian et al., Shenfu injection ameliorates endotoxemia-associated endothelial dysfunction and organ injury via inhibiting PI3K/Akt-mediated glycolysis 💉🫀 Journal of Ethnopharmacology, 2024
  8. Yupeng Zhao et al., H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis 🎗️🧬 Biochemical Pharmacology, 2024
  9. Rui Tian et al., Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2 💊💉 BBA-Molecular basis of disease, 2019
  10. Lei Pei et al., MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response 🧬🩸 International Immunopharmacology, 2024

Conclusion:

Dr. Ranran Li is highly deserving of the Best Researcher Award due to her outstanding contributions to understanding the molecular mechanisms underlying sepsis-related endothelial dysfunction. Her innovative research has not only provided deep insights into the pathophysiology of sepsis but has also uncovered potential therapeutic targets for treating this devastating condition. Her exceptional track record of high-quality publications, patents, and collaborative research, combined with her dedication to advancing critical care medicine, makes her an excellent candidate for this prestigious award.

Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Published on by Cell Biologist

MS. Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Ms. Sunita Pokhrel Bhattarai  , Ohio State University , United States

Sunita Pokhrel Bhattarai, PhD, RN, is an accomplished cardiovascular nurse researcher currently pursuing a doctorate at the University of Rochester, New York. Her research focuses on improving the estimation of Left Ventricular Ejection Fraction using ECGs in acute heart failure patients. With a background in emergency and critical care nursing from multiple international institutions, she is committed to advancing healthcare quality, particularly in heart failure care. Dr. Pokhrel Bhattarai’s work is widely published, showcasing expertise in clinical trials, big data analysis, and electrocardiographic assessments in heart failure. She has also contributed significantly to nursing education as a lecturer at Purbanchal University, Nepal. Passionate about reducing healthcare discrepancies, she actively participates in academic and clinical research collaborations, making significant strides in her field.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Sunita Pokhrel Bhattarai is an exceptional researcher with a clear commitment to advancing cardiovascular nursing and improving healthcare outcomes for acute heart failure patients. Her research on estimating Left Ventricular Ejection Fraction using ECGs demonstrates innovation and clinical relevance. Her ability to bridge clinical practice with advanced research methodologies, including big data analysis and electrocardiographic assessment, sets her apart. Moreover, her international academic background and diverse professional experience in countries like Nepal, Spain, and the United States highlight her versatility and ability to contribute globally to healthcare solutions. Dr. Pokhrel Bhattarai’s consistent publication record in top-tier journals and her involvement in prestigious research projects further underscores her dedication to advancing nursing knowledge.

Areas for Improvement:

While Dr. Pokhrel Bhattarai has an outstanding academic and research profile, expanding her research to explore broader healthcare disparities, particularly in rural or underserved populations, could enhance the impact of her work. Additionally, pursuing interdisciplinary collaborations with engineers, statisticians, and other healthcare professionals could provide opportunities for more cutting-edge innovations, particularly in ECG-based diagnostic technology and AI integration.

Education:

Dr. Sunita Pokhrel Bhattarai has an extensive academic background. She is currently pursuing a PhD in Health Science and Nursing at the University of Rochester (2020-2024), under the mentorship of Dr. Mary G Carey. Her research explores estimating Left Ventricular Ejection Fraction using ECGs for acute heart failure patients. Dr. Pokhrel Bhattarai earned her MS in Nursing (2015-2017), specializing in Emergency and Critical Care Nursing, from institutions across Spain, Portugal, and Finland. Her research during this time focused on Advanced Cardiac Life Support knowledge among critical care nurses. She completed her BS in Nursing in 2012 from Maharajgunj Nursing Campus, Nepal, with a focus on Community Health Nursing. Throughout her academic career, she has demonstrated a commitment to advancing nursing knowledge and improving healthcare outcomes in cardiovascular care.

Experience:

Dr. Sunita Pokhrel Bhattarai has diverse professional experience across multiple countries. She has worked as a Nursing Lecturer at Purbanchal University in Kathmandu, Nepal (2017-2020), where she educated future nurses in critical care and advanced cardiovascular practices. As a registered nurse at Shahid Gangalal National Heart Centre, Kathmandu, Nepal (2009-2015), she gained hands-on experience in cardiovascular care, particularly in heart failure management. Additionally, she has been involved in research coordination and manuscript review, demonstrating expertise in big data analysis and clinical trials. Dr. Pokhrel Bhattarai has also held positions as a Research Lead Coordinator and Associate, collaborating with international researchers and contributing to advancing healthcare outcomes, particularly in cardiovascular nursing.

Awards and Honors:

Dr. Sunita Pokhrel Bhattarai has received numerous prestigious awards, highlighting her excellence in research and commitment to healthcare. In 2023, she was awarded the Travel Grant by the Council on Cardiovascular and Stroke Nursing Early Career, American Heart Association, and received the Presidential Stronger as One Diversity Award from the University of Rochester. She also secured a research grant from the International Society for Computerized Electrocardiology Conference. Dr. Pokhrel Bhattarai’s accomplishments include the Ireta Neumann Scholarship for International Nurses, providing $5,000 to support her research endeavors. These awards emphasize her leadership and contributions to cardiovascular nursing, both academically and clinically.

Research Focus:

Dr. Sunita Pokhrel Bhattarai’s research focus lies in the intersection of acute heart failure, ECG technology, and cardiovascular nursing. Her PhD dissertation explores estimating Left Ventricular Ejection Fraction using ECGs, aiming to provide accurate, non-invasive diagnostic tools for acute heart failure. She is passionate about identifying self-care strategies for heart failure patients and improving healthcare implementation strategies. Additionally, her work involves big data analysis, electrocardiographic assessment, and clinical trials to better understand heart failure progression and outcomes. Dr. Pokhrel Bhattarai is dedicated to addressing healthcare discrepancies, particularly in global cardiovascular health, and advancing evidence-based nursing practices through innovative research.

Publications Top Notes:

  1. Association Between Increased Serum Albumin and the Length of Hospital Stay among Acute Heart Failure 🏥
  2. Delays in Door-to-Diuretic Time and 1-Year Mortality among Patients with Heart Failure ⏳❤️
  3. Signs and Symptoms Clusters Among Patients With Acute Heart Failure 🔍💓
  4. Integrative Review of Electrocardiographic Characteristics in Patients with Reduced, Mildly Reduced, and Preserved Heart Failure 📊📈
  5. Knowledge and Practices on Prevention of Coronary Artery Diseases in Nepalese Community 🇳🇵💓
  6. Estimating Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure 💖📉
  7. Door-to-Diuretic Time is Related to Length of Hospital Stay Independent of Diuretic Dose ⏰💊
  8. Estimating Very Low Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure ❤️📉
  9. Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure 🧑‍⚕️⏱
  10. Estimating Ejection Fraction from the 12 Lead ECG in Acute Heart Failure 💓📝

Conclusion:

Dr. Sunita Pokhrel Bhattarai’s combination of innovative cardiovascular research, global nursing expertise, and dedication to improving patient outcomes makes her an excellent candidate for the Research for Best Researcher Award. Her strong track record in research, awards, and contributions to cardiovascular nursing makes her deserving of this recognition, and her future endeavors hold great potential to further elevate the field of health science and nursing.